期刊文献+

人肠道病毒71型VP0蛋白的原核表达及多克隆抗体制备 被引量:1

Expression of VP0 protein of enterovirus 71 in Escherichia coli and generation of the corresponding polyclonal antibodies in guinea pigs
下载PDF
导出
摘要 目的:原核表达并纯化人肠道病毒71型(EV71)VP0蛋白,免疫豚鼠制备多克隆抗体,并鉴定其用于EV71检测的反应性和特异性。方法:PCR方法扩增VP0基因,构建原核表达质粒pET-VP0并转化大肠杆菌,诱导表达并纯化VP0重组蛋白,免疫豚鼠制备抗VP0多克隆抗体,ELISA方法检测抗VP0抗体效价,细胞免疫荧光和Western blot方法鉴定抗体特异性。结果:VP0重组蛋白在大肠杆菌BL21中高效表达,制备的抗VP0抗体效价为1∶106。细胞免疫荧光及Western blot检测结果显示,抗VP0多克隆抗体可以识别原核表达及EV71感染细胞中的VP0蛋白。结论:原核表达了EV71的VP0蛋白并制备出抗VP0多克隆抗体,为EV71的临床诊断、疫苗开发和分子病毒学研究提供了新的研究工具和手段。 AIM: To obtain recombinant VP0 protein of enterovirus 71,and generate the corresponding VP0-specific polyclonal antibodies,for molecular detection and characterization of EV71.METHODS: The VP0 gene was amplified by PCR and cloned into vector pET26b to make pET-VP0 for the prokaryotic expression of VP0.The recombinant VP0 protein was expressed in E.coli BL21 harboring pET-VP0,purified from inclusion bodies,renatured,and subsequently used to immunize guinea pigs.The resultant antisera were evaluated for anti-VP0 titer,binding capacity and specificity by ELISA,immunofluorescence staining and Western blot assays.RESULTS: Recombinant protein VP0 was efficiently produced in E.coli.Immunization of guinea pigs with recombinant VP0 elicited high-titer(1∶106) VP0-specific antibodies.Western blot analysis showed the resultant anti-VP0 sera reacted with E.coli-expressed VP0 as well as EV71 propagated in Vero cells.Moreover,the antisera positively recognized EV71 infected cells by immunofluorescence staining.CONCLUSION: The recombinant VP0 and the corresponding polyclonal antibodies can be used to identify and characterize EV71,and therefore represent useful agents and tools for the development of new diagnostic methods and vaccines for EV71.
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2011年第5期535-538,共4页 Chinese Journal of Cellular and Molecular Immunology
基金 中国科学院"百人计划"项目(KSCX2-YW-BR-2) 生化工程国家重点实验室开放基金项目(2010KF-07)
关键词 手足口病 人肠道病毒71型 VPO 多克隆抗体 HFMD enterovirus 71 VP0 polyclonal antibody
  • 相关文献

参考文献6

  • 1Solomon T, Lewthwaite P, Perera D, et al. Virology, epidemiology, pathogenesis, and control of enterovirus 71 [ J ]. Lancet Infect Dis, 2010, 10:778-790.
  • 2Yang F, Ren L, Xiong Z, et al. Enterovirus 71 outbreak in the Peo- ple's Republic of China in 2008 [ J]. J Clin Microbiol, 2009, 47: 2351 - 2352.
  • 3Ranganathan S, Singh S, Poh CL, et al. The hand, foot and mouth disease virus capsid: sequence analysis and prediction of antigenic sites from homology modelling[ J ]. Appl Bioinformatics, 2002, 1 : 43 -52.
  • 4Harber JJ, Bradley J, Anderson CW, et al. Catalysis of poliovirus VP0 maturation cleavage is not mediated by serine 10 of VP2[J]. J Virol , 1991,65 : 326 -334.
  • 5Lee MS, Chang LY. Development of enterovirus 71 v.accines [ J]. Vaccine, 2010, 9(2) : 149 - 156.
  • 6Xu J, Qian Y, Wang S, et al. EV71 : an emerging infectious disease vaccine target in the Far East[ J]. Vaccine, 2010, 28:3516 -3521.

同被引文献19

  • 1lshimaru Y, Nakano S, Yamaoka K, et al. Outbreaks of hand 3hot,and mouth disease by enterovirus 71. High incidence of complication disorders of central nervous system [J]. Arch Dis Child,1980,55(8): 583-588.
  • 2Schmidt N J, Lennette EH, Ho HH. An apparently new enterovirus isolated from patients with disease of the central nervous system[J]. J Infect Dis 1974 129:304-309.
  • 3Brown, B. A. & Pallansch, M. A. (1995). Complete nucleotide sequence of enterovirus 71 is distinct from poliovirus[J]. Virus Resea- rch, 1995,39:195-205.
  • 4Foo DG, Macary PA, Aloson S, et al. Identification of human CD4 T-cell epitopes on the VP1 caspid protein ofenterovirus 71 [J] .Viral lmmuno,2008,21(2):215-224.
  • 5Shih SR, Li YS, Chiou CC, et al. Expression ofcapsid [correction of caspid] protein VPI for use as antigen for the diagnosis of enterovirus 71 infection[J]. J Med Virol,2000,61 (2):228-234.
  • 6Hu YC, Hsu JT, Huang JH, et al. Formation of enterovirus-like particle aggregates by recombinant baculovirus co-expression PI and 3CD in insect cells[J]. Biotechnology Lettlers,2003,25( 12):919-925.
  • 7Ho M, Chen ER, Hsu KH, et al. An Epidemic of enterovirus 71 infection in Taiwan[J]. N Engl J Med,1999,341:929-935.
  • 8Lee MS, Chang LY. Development of enterovirus 71 vaccines [J]. Expert Rev Vaccines,2010,9(2): 149-156.
  • 9Huang Sheng-wen, HsuYun-Wei, Derek J. Smith, et al. Reemergence of Enterovirus 71 in 2009 in Taiwan:Dynamics of Genetic and antigenic Evolution from 1998 to 2008 [J]. J Clin Microbiol,2009,47: 3653-3662.
  • 10Lin KH,Hwang KP, Ke GM, et al, Evolution of EV71 genogroup in Taiwan from 1998 to 2005:an emerging of subgenogroup C4 of EV71 [J]. J Med Virol,2006,78:254-262.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部